These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1354573)
41. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites. Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940 [TBL] [Abstract][Full Text] [Related]
42. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Villanueva C; Planella M; Aracil C; López-Balaguer JM; González B; Miñana J; Balanzó J Am J Gastroenterol; 2005 Mar; 100(3):624-30. PubMed ID: 15743361 [TBL] [Abstract][Full Text] [Related]
43. Octreotide bolus injection and azygos blood flow in patients with cirrhosis: is the effect really predictable? Spahr L; Giostra E; Mentha G; Hadengue A J Clin Gastroenterol; 2010 Oct; 44(9):e206-9. PubMed ID: 19996986 [TBL] [Abstract][Full Text] [Related]
44. Splanchnic and hepatic metabolism of somatostatin: a study in cirrhotic patients with a portacaval shunt. Webb S; Kravetz D; Bosch J; Wass JA; Evans J; Gomis R; Rees LH; Rodés J Hepatology; 1983; 3(2):193-7. PubMed ID: 6131859 [TBL] [Abstract][Full Text] [Related]
45. Rat liver injury induced by hypoxic ischemia and reperfusion: protective action by somatostatins is independent from changes in glucose metabolism. Bloechle C; Kusterer K; Konrad T; Hosch SB; Izbicki JR; Knoefel WT; Broelsch CE; Usadel KH Horm Metab Res; 1994 Jun; 26(6):270-5. PubMed ID: 7927189 [TBL] [Abstract][Full Text] [Related]
46. Verapamil pharmacokinetics and liver function in patients with cirrhosis. Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854 [TBL] [Abstract][Full Text] [Related]
47. Effects of losartan, somatostatin and losartan plus somatostatin on portal hemodynamics and renal functions in cirrhosis. Hülagü S; Sentürk O; Erdem A; Ozgür O; Celebi A; Karakaya AT; Seyhogullari M; Demirci A Hepatogastroenterology; 2002; 49(45):783-7. PubMed ID: 12063990 [TBL] [Abstract][Full Text] [Related]
48. The effect of somatostatin analogue on glucose homeostasis in conscious dogs. Nakanishi I; Ishida T; Hosokawa H; Kawanishi K; Hartley CJ; Takahara J Acta Med Okayama; 1997 Feb; 51(1):1-7. PubMed ID: 9057928 [TBL] [Abstract][Full Text] [Related]
49. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420 [TBL] [Abstract][Full Text] [Related]
50. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis. Chatila R; Ferayorni L; Gupta T; Groszmann RJ Hepatology; 2000 Mar; 31(3):572-6. PubMed ID: 10706544 [TBL] [Abstract][Full Text] [Related]
51. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat. Jenkins SA; Devitt P; Day DW; Baxter JN; Shields R Digestion; 1986; 33(3):126-34. PubMed ID: 2868955 [TBL] [Abstract][Full Text] [Related]
52. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells. Klironomos S; Notas G; Sfakianaki O; Kiagiadaki F; Xidakis C; Kouroumalis E Regul Pept; 2014 Jan; 188():5-12. PubMed ID: 24291170 [TBL] [Abstract][Full Text] [Related]
53. [Morphologic studies on the occurrence of HBs antigen in liver cirrhoses, epicirrhotic and pure cancers in a large autopsy sample]. Riedel H; Hensel J; Justus J Dtsch Z Verdau Stoffwechselkr; 1983; 43(1):9-16. PubMed ID: 6840031 [TBL] [Abstract][Full Text] [Related]
54. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107 [TBL] [Abstract][Full Text] [Related]
55. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Fort J; Oberti F; Pilette C; Veal N; Gallois Y; Douay O; Rousselet MC; Rosenbaum J; Calès P Hepatology; 1998 Dec; 28(6):1525-31. PubMed ID: 9828216 [TBL] [Abstract][Full Text] [Related]
56. Somatostatin or octreotide in acute variceal bleeding. Hadengue A Digestion; 1999; 60 Suppl 2():31-41. PubMed ID: 10207229 [TBL] [Abstract][Full Text] [Related]
57. Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers. Burggraaf J; Schoemaker RC; Lentjes EG; Cohen AF Eur J Pharm Sci; 2000 Dec; 12(2):133-9. PubMed ID: 11102741 [TBL] [Abstract][Full Text] [Related]
58. The pharmacokinetics of octreotide in cirrhosis and in healthy man. Ottesen LH; Flyvbjerg A; Jakobsen P; Bendtsen F J Hepatol; 1997 May; 26(5):1018-25. PubMed ID: 9186832 [TBL] [Abstract][Full Text] [Related]
59. [Essential choline phospholipids and their effect on HBsAg and selected biochemical tests in cirrhosis of the liver (author's transl)]. Fassati P; Horejsí J; Fassati M; Spízek J; Jezková Z Cas Lek Cesk; 1981 Jan; 120(2):56-60. PubMed ID: 7471152 [No Abstract] [Full Text] [Related]
60. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation. Tietge UJ; Bahr MJ; Manns MP; Böker KH Liver Transpl; 2001 Dec; 7(12):1015-22. PubMed ID: 11753903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]